We are excited to announce an important milestone in our journey – the merger of Delvin Formulations and Saimirra. This significant step forward is markup and milestone of the excellence and growth in the pharmaceutical industry.

Delvin Formulations have long been recognized for their dedication to innovation, quality, and customer satisfaction. With decades of experience, Delvin have built strong foundations and earned the trust of healthcare professionals and patients alike. With this merger Saimirra will continue to drive its excellence to enhance patient care, expand our innovation towards products, and strengthen our position in the market. By combining our expertise, and capabilities, we will be better equipped to meet the evolving needs of our customers and drive sustainable growth.

As we embark on this exciting journey together, we want to express our sincere gratitude to our employees, customers, suppliers, and shareholders for their continued support. Together, we will build a stronger, more resilient organization that delivers value and innovation for years to come.

Saimirra Innopharm will take on the responsibility of Delvin Formulations and continuing the legacy of innovation and excellence that Delvin Formulations is known for.

Destiny for innovation